In Vivo Contract Research Organization (CRO)

World Market Report

MCP22021

EXECUTIVE ENGAGEMENTS

POOL

703
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

141
Interactions with Platform & by Email

PARTICIPANTS

28
Unique # Participated

VALIDATIONS

11
Responses Validated*

COMPANIES

34
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2022

TABLES

22

PAGES

89

EDITION

5

PRICE

USD 5600

CODE

MCP22021


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

STRONG ACTIVE NICHE TRIVIAL

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What's New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Amid the COVID-19 crisis, the global market for In Vivo Contract Research Organization (CRO) estimated at US$3.8 Billion in the year 2020, is projected to reach a revised size of US$6.6 Billion by 2027, growing at aCAGR of 8% over the period 2020-2027. Rodend-based, one of the segments analyzed in the report, is projected to record 8.1% CAGR and reach US$6.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Rodend based segment is readjusted to a revised 5.7% CAGR for the next 7-year period.
The In Vivo Contract Research Organization (CRO) market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 7.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.5% and 6.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

SELECT PLAYERS

American Preclinical Services, LLC.; Charles River Laboratories; Covance Inc.; Evotec (US), Inc.; ICON Plc; inVentiv Health; Parexel International; Pharmaceutical Product Development, LLC (PPD); Quintiles; Theorem Clinical research; WuXi AppTec, Inc.

SEGMENTS

» Product Type (Rodend-based, Non-Rodend based) » Toxicology (GLP, Non-GLP) » Indication (Oncology, Autoimmune / Inflammatory Conditions, Pain Management, Other Indications)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
In Vivo Contract Research Organization (CRO) – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for In Vivo Contract Research Organization (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Rodend-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Rodend-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Rodend-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Non-Rodend based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Non-Rodend based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Non-Rodend based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for GLP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for GLP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for GLP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Non-GLP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Non-GLP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Non-GLP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Autoimmune / Inflammatory Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Autoimmune / Inflammatory Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Autoimmune / Inflammatory Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World In Vivo Contract Research Organization (CRO) Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
UNITED STATES
In Vivo Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Product Type - Percentage Breakdown of Value Sales for Rodend-based and Non-Rodend based for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Toxicology - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Indication - Percentage Breakdown of Value Sales for Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Product Type - Percentage Breakdown of Value Sales for Rodend-based and Non-Rodend based for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Toxicology - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Indication - Percentage Breakdown of Value Sales for Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications for the Years 2012, 2021 & 2027
JAPAN
In Vivo Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Product Type - Percentage Breakdown of Value Sales for Rodend-based and Non-Rodend based for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Toxicology - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Indication - Percentage Breakdown of Value Sales for Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications for the Years 2012, 2021 & 2027
CHINA
In Vivo Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Product Type - Percentage Breakdown of Value Sales for Rodend-based and Non-Rodend based for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Toxicology - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Indication - Percentage Breakdown of Value Sales for Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications for the Years 2012, 2021 & 2027
EUROPE
In Vivo Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for In Vivo Contract Research Organization (CRO) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Product Type - Percentage Breakdown of Value Sales for Rodend-based and Non-Rodend based for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Toxicology - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Indication - Percentage Breakdown of Value Sales for Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications for the Years 2012, 2021 & 2027
FRANCE
In Vivo Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Product Type - Percentage Breakdown of Value Sales for Rodend-based and Non-Rodend based for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Toxicology - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Indication - Percentage Breakdown of Value Sales for Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications for the Years 2012, 2021 & 2027
GERMANY
In Vivo Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Product Type - Percentage Breakdown of Value Sales for Rodend-based and Non-Rodend based for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Toxicology - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Indication - Percentage Breakdown of Value Sales for Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Product Type - Percentage Breakdown of Value Sales for Rodend-based and Non-Rodend based for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Toxicology - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Indication - Percentage Breakdown of Value Sales for Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications for the Years 2012, 2021 & 2027
UNITED KINGDOM
In Vivo Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Product Type - Percentage Breakdown of Value Sales for Rodend-based and Non-Rodend based for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Toxicology - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Indication - Percentage Breakdown of Value Sales for Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Product Type - Percentage Breakdown of Value Sales for Rodend-based and Non-Rodend based for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Toxicology - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Indication - Percentage Breakdown of Value Sales for Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications for the Years 2012, 2021 & 2027
ASIA-PACIFIC
In Vivo Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Product Type - Percentage Breakdown of Value Sales for Rodend-based and Non-Rodend based for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Toxicology - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Indication - Percentage Breakdown of Value Sales for Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications for the Years 2012, 2021 & 2027
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for In Vivo Contract Research Organization (CRO) by Product Type - Rodend-based and Non-Rodend based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Product Type - Percentage Breakdown of Value Sales for Rodend-based and Non-Rodend based for the Years 2012, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for In Vivo Contract Research Organization (CRO) by Toxicology - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Toxicology - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2012, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for In Vivo Contract Research Organization (CRO) by Indication - Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for In Vivo Contract Research Organization (CRO) by Indication - Percentage Breakdown of Value Sales for Oncology, Autoimmune / Inflammatory Conditions, Pain Management and Other Indications for the Years 2012, 2021 & 2027
Total Companies Profiled: 34

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com